M/s. IDA Trading MEA C/O Kuehne + N Pharmaceutical Import Profile — United Arab Emirates (DGFT 2022–2026)

Name: M/s. IDA Trading MEA C/O Kuehne + N Pharmaceutical Import Records from India — 3 Products, $700.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

M/s. IDA Trading MEA C/O Kuehne + N — Pharmaceutical Importer Profile (2026) | 3 Products, $700.0K Trade | TransData Nexus

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Fluoxetine	CNS & Psychiatric	$300.0K	6	0.1%	18
2	Ciprofloxacin	Antibiotics	$200.0K	4	0.1%	16
3	Ofloxacin	Advanced Antibiotics	$200.0K	4	0.1%	18

M/s. IDA Trading MEA C/O Kuehne + N imports 3 pharmaceutical products across 3 categories into United Arab Emirates totaling $700.0K.

M/s. IDA Trading MEA C/O Kuehne + N — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

M/s. IDA Trading MEA C/O Kuehne + N is a pharmaceutical importer based in the United Arab Emirates (UAE), specializing in the procurement of finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. Operating under the auspices of Kuehne + Nagel, a global logistics and supply chain management company, IDA Trading MEA serves as a conduit for pharmaceutical products entering the UAE market. The company is headquartered in Dubai Logistics City, P.O. Box 22577, Dubai, UAE.

In the UAE's pharmaceutical distribution landscape, M/s. IDA Trading MEA C/O Kuehne + N functions as a key importer, facilitating the entry of pharmaceutical products into the country. By leveraging Kuehne + Nagel's extensive logistics network, the company ensures efficient handling and distribution of pharmaceutical goods, thereby contributing to the availability of essential medications within the UAE.

2Distribution Network

While specific details regarding M/s. IDA Trading MEA C/O Kuehne + N's warehouse locations and logistics capabilities are not publicly disclosed, it is reasonable to infer that, as part of the Kuehne + Nagel group, the company benefits from a robust distribution network. Kuehne + Nagel operates numerous facilities worldwide, including in the UAE, which likely supports the efficient storage and distribution of pharmaceutical products imported by IDA Trading MEA. This extensive network enables the company to manage inventory effectively and ensure timely delivery of products across the UAE and potentially to other regions.

3Industry Role

M/s. IDA Trading MEA C/O Kuehne + N primarily functions as a pharmaceutical importer in the UAE's supply chain. By sourcing finished pharmaceutical formulations from international suppliers, particularly from India, the company plays a crucial role in ensuring the availability of a diverse range of medications within the UAE market. This importation process involves compliance with UAE's regulatory requirements and coordination with various stakeholders to facilitate the smooth entry of pharmaceutical products into the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — M/s. IDA Trading MEA C/O Kuehne + N

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

An analysis of M/s. IDA Trading MEA C/O Kuehne + N's sourcing patterns reveals a significant concentration in its procurement activities. The company has imported a total of $700,000 worth of pharmaceutical products from India over 14 shipments, focusing on three therapeutic categories: Central Nervous System (CNS) & Psychiatric, Antibiotics, and Advanced Antibiotics. The top three products imported are Fluoxetine ($300,000), Ciprofloxacin ($200,000), and Ofloxacin ($200,000), collectively accounting for 100% of the company's imports.

This sourcing strategy indicates a high dependency on a limited number of products and suppliers, which could pose risks such as supply chain disruptions or price volatility. However, this concentration may also reflect a strategic choice to focus on high-demand medications within specific therapeutic areas, aligning with market needs and ensuring a steady supply of essential drugs.

2Supply Chain Resilience

The resilience of M/s. IDA Trading MEA C/O Kuehne + N's supply chain is influenced by its concentrated sourcing strategy. Relying heavily on a few products and suppliers, particularly from India, may expose the company to risks associated with geopolitical tensions, regulatory changes, or disruptions in the Indian pharmaceutical industry. To mitigate these risks, it is essential for the company to establish relationships with multiple suppliers, diversify its product portfolio, and develop contingency plans to ensure a continuous supply of pharmaceutical products to the UAE market.

Importing Pharmaceuticals into United Arab Emirates — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United Arab Emirates

1Regulatory Authority & Framework

The United Arab Emirates' pharmaceutical sector is regulated by the Emirates Drug Establishment (EDE), which operates under the Ministry of Health and Prevention. The EDE is responsible for overseeing the import, distribution, and marketing of medical products within the UAE. Key legislation governing pharmaceutical imports includes the Federal Decree-Law No. 8 of 2019 on Medical Products, Pharmacy Profession, and Pharmaceutical Facilities, which outlines the regulatory framework for medical products in the UAE. (uaelegislation.gov.ae)

The EDE's role encompasses ensuring the safety, efficacy, and quality of medical products entering the UAE market. This involves setting standards for pharmaceutical establishments, monitoring compliance with regulations, and implementing policies to safeguard public health. The EDE also collaborates with other health authorities to track and monitor the circulation of medical products, enhancing supply chain security and transparency. (uaelegislation.gov.ae)

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in the UAE are stringent. Companies like M/s. IDA Trading MEA C/O Kuehne + N must obtain import permits from the EDE for each shipment, ensuring that imported products meet the necessary safety, quality, and efficacy standards. Additionally, the EDE requires that pharmaceutical establishments hold valid Good Manufacturing Practice (GMP) certificates, which can be recognized from various international standards such as EU GMP, WHO GMP, or PIC/S. This recognition ensures that imported products are manufactured in facilities adhering to internationally accepted quality standards. (uaelegislation.gov.ae)

M/s. IDA Trading MEA C/O Kuehne + N — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

M/s. IDA Trading MEA C/O Kuehne + N's focus on importing pharmaceutical products in the CNS & Psychiatric, Antibiotics, and Advanced Antibiotics categories aligns with the UAE's healthcare priorities. The high import values of Fluoxetine, Ciprofloxacin, and Ofloxacin indicate a strategic emphasis on essential medications that address prevalent health concerns in the region. This product strategy ensures that the company meets the market demand for critical therapeutic areas, contributing to the overall health and well-being of the UAE population.

2Sourcing Profile

M/s. IDA Trading MEA C/O Kuehne + N's sourcing strategy is centered on procuring generic pharmaceutical products from India, focusing on formulations that are in high demand within the UAE market. The company's preference for finished pharmaceutical formulations over raw Active Pharmaceutical Ingredients (APIs) suggests a strategic approach to meet the immediate needs of healthcare providers and patients. India's well-established pharmaceutical manufacturing sector, known for its adherence to international quality standards, makes it a reliable source for these products.

3Market Positioning

Seller's Guide — How to Become a Supplier to M/s. IDA Trading MEA C/O Kuehne + N

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For new Indian pharmaceutical suppliers, there is a realistic opportunity to partner with M/s. IDA Trading MEA C/O Kuehne + N by offering products that align with the company's strategic focus on high-demand therapeutic areas. Gaps in the company's current sourcing may include a limited range of formulations or specific dosage forms. By addressing these gaps, Indian exporters can enhance their competitiveness and establish a strong presence in the UAE market through collaboration with the company.

2Requirements & Qualifications

Indian exporters aiming to supply M/s. IDA Trading MEA C/O Kuehne + N must ensure that their products comply with the UAE's regulatory requirements. This includes obtaining necessary import permits from the EDE, ensuring that manufacturing facilities hold valid GMP certificates recognized by the UAE, and adhering to quality and labeling standards. Additionally, products must meet the UAE's serialization mandates to facilitate traceability and prevent counterfeit products from entering the market.

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — M/s. IDA Trading MEA C/O Kuehne + N

What products does M/s. IDA Trading MEA C/O Kuehne + N import from India?

M/s. IDA Trading MEA C/O Kuehne + N imports 3 pharmaceutical products across 3 categories. Top imports: Fluoxetine ($300.0K), Ciprofloxacin ($200.0K), Ofloxacin ($200.0K).

What is M/s. IDA Trading MEA C/O Kuehne + N's total pharmaceutical import value?

M/s. IDA Trading MEA C/O Kuehne + N's total pharmaceutical import value from India is $700.0K, based on 14 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does M/s. IDA Trading MEA C/O Kuehne + N focus on?

M/s. IDA Trading MEA C/O Kuehne + N imports across 3 categories. The largest: CNS & Psychiatric (42.9%), Antibiotics (28.6%), Advanced Antibiotics (28.6%).

Get Full M/s. IDA Trading MEA C/O Kuehne + N Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

M/s. IDA Trading MEA C/O Kuehne + N

M/s. IDA Trading MEA C/O Kuehne + N — Import Portfolio & Supplier Network

What Products Does M/s. IDA Trading MEA C/O Kuehne + N Import?

Top Products by Import Value

M/s. IDA Trading MEA C/O Kuehne + N Therapeutic Categories — 3 Specializations